Molecure S.A. (WAR:MOC) — Stock Price
Molecure S.A. (WAR:MOC) is currently trading at zł6.07 PLN, up 0.33% today. Over the past 52 weeks, shares have ranged between zł5.11 and zł8.68. This page tracks Molecure S.A.'s live share price on the WAR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Molecure S.A. (MOC) total market value.
Molecure S.A. (MOC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Molecure S.A.'s daily closing share price and trading volume on the WAR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Molecure S.A. Income Statement — Revenue, Profit & Earnings by Year
Molecure S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | zł2.92 Million | zł100.00 | zł7.51 Million | zł400.00 | zł122.94 Million |
| Cost of Revenue | zł3.41 Million | zł4.10 Million | zł1.63 Million | zł2.77 Million | zł38.41 Million |
| Gross Profit | zł-489.91K | zł-4.10 Million | zł-21.33K | zł-2.77 Million | zł84.53 Million |
| Research & Development | zł2.36 Million | zł2.72 Million | zł11.63 Million | zł2.59 Million | zł38.31 Million |
| SG&A | — | — | zł6.03 Million | zł4.03 Million | zł4.28 Million |
| Total Operating Expenses | zł31.81 Million | zł28.03 Million | zł16.26 Million | zł5.27 Million | zł10.83 Million |
| Operating Income | zł-33.61 Million | zł-32.13 Million | zł-43.91 Million | zł-13.76 Million | zł73.70 Million |
| EBITDA | zł-27.37 Million | zł-25.51 Million | zł-31.85 Million | zł-13.33 Million | zł73.88 Million |
| EBIT | zł-31.19 Million | zł-28.33 Million | zł-35.83 Million | zł-13.63 Million | zł73.66 Million |
| Interest Expense | zł94.23K | zł89.20K | zł16.36K | zł6.48K | zł6.21K |
| Income Before Tax | zł-31.29 Million | zł-28.37 Million | zł-35.95 Million | zł-13.64 Million | zł73.65 Million |
| Income Tax Expense | — | — | zł-1.72 Million | zł6.24K | zł5.69 Million |
| Net Income | zł-31.29 Million | zł-28.37 Million | zł-13.54 Million | zł-13.64 Million | zł67.96 Million |
Molecure S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Molecure S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | zł113.72 Million | zł112.27 Million | zł138.06 Million | zł151.59 Million | zł153.50 Million |
| Total Current Assets | zł50.26 Million | zł65.71 Million | zł74.99 Million | zł115.94 Million | zł130.08 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | zł30.32 Million | zł9.64K | zł15.39K | zł13.45 Million | zł13.08 Million |
| Inventory | — | — | — | — | zł-3.69 Million |
| Property, Plant & Equipment | — | — | — | zł9.82 Million | zł7.89 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | zł10.31 Million | zł11.34 Million | zł11.61 Million | zł10.45 Million | zł10.09 Million |
| Total Current Liabilities | zł5.12 Million | zł6.04 Million | zł6.98 Million | zł6.16 Million | zł6.61 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | zł-10.96 Million | zł-56.85 Million | zł-59.21 Million | zł-96.03 Million | zł-115.27 Million |
| Total Stockholder Equity | zł103.41 Million | zł100.93 Million | zł126.45 Million | zł141.14 Million | zł147.09 Million |
| Retained Earnings | zł-81.28 Million | zł-49.99 Million | zł24.62 Million | zł39.88 Million | zł53.52 Million |
Molecure S.A. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Molecure S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | zł-56.99 Million | zł-23.29 Million | zł-10.21 Million | zł-13.50 Million | zł57.44 Million |
| Capital Expenditures | zł23.77 Million | zł362.23K | zł33.63 Million | zł18.83 Million | zł2.09 Million |
| Free Cash Flow | zł-80.76 Million | zł-23.65 Million | zł-43.84 Million | zł-32.33 Million | zł55.35 Million |
| Investing Cash Flow | zł-23.57 Million | zł-33.87 Million | zł-33.59 Million | zł-18.82 Million | zł8.58 Million |
| Financing Cash Flow | zł34.76 Million | zł55.53 Million | zł7.38 Million | zł13.86 Million | zł20.45 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | zł4.04 Million | zł0.00 | zł441.60K | zł2.83 Million | zł350.28K |
| Depreciation | zł3.82 Million | zł2.83 Million | zł1.31 Million | zł299.82K | zł218.37K |
| Change in Cash | zł-45.80 Million | zł-1.63 Million | zł-36.42 Million | zł-18.46 Million | zł86.46 Million |
Molecure S.A. Earnings History — EPS Actual vs. Analyst Estimates
Track Molecure S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.26 | — | — |
| Jun 30, 2025 | -0.17 | — | — |
| Mar 31, 2025 | -0.26 | — | — |
| Mar 28, 2025 | -0.52 | — | — |
| Oct 14, 2024 | -0.37 | — | — |
| Jun 30, 2024 | -0.63 | — | — |
| Mar 31, 2024 | -0.41 | — | — |
| Mar 28, 2024 | -0.40 | — | — |